Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Patterson

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Reproductive Biomedicine Online|August 24, 2010
A universal carrier test for the long tail of Mendelian diseaseBalaji S Srinivasan, Eric A Evans, Jason Flannick, et al.
The Pediatric Infectious Disease Journal|October 30, 2012
Antibody responses to routine pediatric vaccines administered with 13-valent pneumococcal conjugate vaccineKristina A Bryant, Alejandra Gurtman, Douglas Girgenti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2016
Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapyLucy Lim, Alexander Thompson, Scott Patterson, et al.
Vaccine|October 27, 2012
A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in BrazilLily Yin Weckx, Allison Thompson, Eitan Naaman Berezin, et al.
The Pediatric Infectious Disease Journal|October 19, 2013
13-Valent pneumococcal conjugate vaccine in older children and adolescents either previously immunized with or naïve to 7-valent pneumococcal conjugate vaccineRobert Frenck, Allison Thompson, Shelly Senders, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 17, 2018
Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target EngagementHelen Yu, Hoa Truong, Scott A Mitchell, et al.
Pediatrics|August 25, 2010
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlersSylvia H Yeh, Alejandra Gurtman, David C Hurley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 15, 2012
An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individualsGabriel A Lazarin, Imran S Haque, Shivani Nazareth, et al.
Human Vaccines & Immunotherapeutics|October 11, 2018
Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trialAllison R Thompson, Nicola P Klein, H Jackson Downey, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2008
Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRASUdayan Guha, Raghothama Chaerkady, Arivusudar Marimuthu, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Reproductive Biomedicine Online|August 24, 2010
A universal carrier test for the long tail of Mendelian diseaseBalaji S Srinivasan, Eric A Evans, Jason Flannick, et al.
The Pediatric Infectious Disease Journal|October 30, 2012
Antibody responses to routine pediatric vaccines administered with 13-valent pneumococcal conjugate vaccineKristina A Bryant, Alejandra Gurtman, Douglas Girgenti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2016
Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapyLucy Lim, Alexander Thompson, Scott Patterson, et al.
Vaccine|October 27, 2012
A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in BrazilLily Yin Weckx, Allison Thompson, Eitan Naaman Berezin, et al.
The Pediatric Infectious Disease Journal|October 19, 2013
13-Valent pneumococcal conjugate vaccine in older children and adolescents either previously immunized with or naïve to 7-valent pneumococcal conjugate vaccineRobert Frenck, Allison Thompson, Shelly Senders, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 17, 2018
Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target EngagementHelen Yu, Hoa Truong, Scott A Mitchell, et al.
Pediatrics|August 25, 2010
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlersSylvia H Yeh, Alejandra Gurtman, David C Hurley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 15, 2012
An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individualsGabriel A Lazarin, Imran S Haque, Shivani Nazareth, et al.
Human Vaccines & Immunotherapeutics|October 11, 2018
Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trialAllison R Thompson, Nicola P Klein, H Jackson Downey, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2008
Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRASUdayan Guha, Raghothama Chaerkady, Arivusudar Marimuthu, et al.
Pageof 7